Is AKBA stock a good buy?
Is AKBA stock a good buy?
Akebia Therapeutics Inc (NASDAQ:AKBA) The 3 analysts offering 12-month price forecasts for Akebia Therapeutics Inc have a median target of 1.25, with a high estimate of 2.00 and a low estimate of 1.00. The median estimate represents a +242.28% increase from the last price of 0.37.
Is akebia a public company?
Akebia Therapeutics, Inc. today announced the pricing of its initial public offering of 5,882,353 shares of common stock at an initial public offering price of $17.00 per share.
How many shares does AKBA have?
183.53 million shares
Share Statistics AKBA has 183.53 million shares outstanding.
What does Akebia Therapeutics do?
We are a leader in the renal community – a fully integrated biopharmaceutical company with capabilities ranging from research through commercialization. We have a portfolio focused on addressing significant unmet needs for people living with kidney disease.
Who owns AKBA stock?
Top 10 Owners of Akebia Therapeutics Inc
Stockholder | Stake | Shares owned |
---|---|---|
The Vanguard Group, Inc. | 10.00% | 18,359,420 |
BlackRock Fund Advisors | 6.70% | 12,291,416 |
SSgA Funds Management, Inc. | 6.26% | 11,488,224 |
JPMorgan Investment Management, I… | 2.07% | 3,800,050 |
Why is AKBA down?
What happened. Shares of Akebia Therapeutics (NASDAQ: AKBA) are plunging today, down 72.3% as of 11:15 a.m. EDT, after the company announced results from a late-stage study of vadadustat in treating anemia due to chronic kidney disease (CKD) in adult patients not on dialysis.
Why is AKBA down today?
Shares of Akebia Therapeutics (NASDAQ: AKBA) are plunging today, down 72.3% as of 11:15 a.m. EDT, after the company announced results from a late-stage study of vadadustat in treating anemia due to chronic kidney disease (CKD) in adult patients not on dialysis.
Who owns AKBA?
Largest shareholders include Vanguard Group Inc, BlackRock Inc., State Street Corp, XBI – SPDR(R) S&P(R) Biotech ETF, VTSMX – Vanguard Total Stock Market Index Fund Investor Shares, Satter Management Co., L.p., Jpmorgan Chase & Co, IWM – iShares Russell 2000 ETF, Geode Capital Management, Llc, and Dimensional Fund …
Where is akebia located?
Native Range: China, Japan and Korea (REHD, BAIL); Appearance. Akebia quinata is an invasive deciduous to evergreen climbing or trailing vine that invades forested areas throughout the eastern United States….
chocolate vine | USDA PLANTS Symbol: AKQU U.S. Nativity: Exotic Habit: Vines |
---|---|
Akebia quinata (Houtt.) Dcne. |
Does FDA approve vadadustat?
The decision by the FDA not to approve vadadustat for patients on dialysis was surprising and disappointing to nephrologists hoping for a safe and effective oral alternative to erythropoiesis-stimulating agents for treatment of anemia.
Can you eat Akebia?
The mild, viscous pulp of the soft fruit is eaten raw with lemons juice or pureed and made into a cream or a drink. It has a slight coconut milk flavor. Young shoots are used in salads or for salt pickling. The bitter skin of the fruit is fried and eaten and the leaves used as a tea substitute.
Why is Akebia called chocolate vine?
An Asian plant, Akebia quinata, it is called the chocolate vine because of its springtime vanilla-scented flowers. This edible curiosity is cultivated for food in Japan. It is hard to believe that this large fat fruit is produced from such small purple flowers.